107 related articles for article (PubMed ID: 27139580)
1. Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia.
Yamazaki Y; Harada S; Wada T; Yoshida S; Tokuyama S
J Pharm Pharmacol; 2016 Jul; 68(7):922-31. PubMed ID: 27139580
[TBL] [Abstract][Full Text] [Related]
2. Sodium influx through cerebral sodium-glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage.
Yamazaki Y; Harada S; Wada T; Hagiwara T; Yoshida S; Tokuyama S
Eur J Pharmacol; 2017 Mar; 799():103-110. PubMed ID: 28174043
[TBL] [Abstract][Full Text] [Related]
3. Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter.
Yamazaki Y; Harada S; Tokuyama S
Brain Res; 2012 Dec; 1489():113-20. PubMed ID: 23078759
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia.
Yamazaki Y; Harada S; Tokuyama S
Neurosci Lett; 2015 Sep; 604():134-9. PubMed ID: 26254165
[TBL] [Abstract][Full Text] [Related]
5. Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia.
Yamazaki Y; Ogihara S; Harada S; Tokuyama S
Neuroscience; 2015 Dec; 310():674-85. PubMed ID: 26454021
[TBL] [Abstract][Full Text] [Related]
6. Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage.
Yamazaki Y; Harada S; Tokuyama S
Neuroscience; 2014 Jun; 269():134-42. PubMed ID: 24699226
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia.
Harada S; Yamazaki Y; Nishioka H; Tokuyama S
Brain Res; 2013 Dec; 1541():61-8. PubMed ID: 24134951
[TBL] [Abstract][Full Text] [Related]
8. Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1.
Yamazaki Y; Arita K; Harada S; Tokuyama S
J Pharmacol Sci; 2018 Dec; 138(4):240-246. PubMed ID: 30503674
[TBL] [Abstract][Full Text] [Related]
9. [Potential of the Cerebral Sodium-Glucose Transporter as a Novel Therapeutic Target in Cerebral Ischemia].
Yamazaki Y; Harada S; Tokuyama S
Yakugaku Zasshi; 2018; 138(7):955-962. PubMed ID: 29962475
[TBL] [Abstract][Full Text] [Related]
10. Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia.
Chen H; Luo J; Kintner DB; Shull GE; Sun D
J Cereb Blood Flow Metab; 2005 Jan; 25(1):54-66. PubMed ID: 15678112
[TBL] [Abstract][Full Text] [Related]
11. A fluorescence method for measurement of glucose transport in kidney cells.
Blodgett AB; Kothinti RK; Kamyshko I; Petering DH; Kumar S; Tabatabai NM
Diabetes Technol Ther; 2011 Jul; 13(7):743-51. PubMed ID: 21510766
[TBL] [Abstract][Full Text] [Related]
12. Sodium-glucose cotransporters display sodium- and phlorizin-dependent water permeability.
Loike JD; Hickman S; Kuang K; Xu M; Cao L; Vera JC; Silverstein SC; Fischbarg J
Am J Physiol; 1996 Nov; 271(5 Pt 1):C1774-9. PubMed ID: 8944663
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats.
Yamaguchi K; Kato M; Suzuki M; Asanuma K; Aso Y; Ikeda S; Ishigai M
Drug Metab Dispos; 2011 Oct; 39(10):1801-7. PubMed ID: 21712434
[TBL] [Abstract][Full Text] [Related]
14. Na+-dependent and phlorizin-inhibitable transport of glucose and cycasin in brain endothelial cells.
Matsuoka T; Nishizaki T; Kisby GE
J Neurochem; 1998 Feb; 70(2):772-7. PubMed ID: 9453573
[TBL] [Abstract][Full Text] [Related]
15. Sodium-independent low-affinity D-glucose transport by human sodium/D-glucose cotransporter 1: critical role of tryptophan 561.
Kumar A; Tyagi NK; Goyal P; Pandey D; Siess W; Kinne RK
Biochemistry; 2007 Mar; 46(10):2758-66. PubMed ID: 17288452
[TBL] [Abstract][Full Text] [Related]
16. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.
Vemula S; Roder KE; Yang T; Bhat GJ; Thekkumkara TJ; Abbruscato TJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):487-95. PubMed ID: 18981287
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin 2 deficiency does not affect cortical neuronal viability in response to oxygen-glucose-deprivation and transient middle cerebral artery occlusion.
Hou ST; Jiang SX; Slinn J; O'Hare M; Karchewski L
Neurosci Res; 2010 Apr; 66(4):396-401. PubMed ID: 20036291
[TBL] [Abstract][Full Text] [Related]
18. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells.
Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ
J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of SGLT2 by tofogliflozin or phlorizin induces urinary glucose excretion through extending splay in cynomolgus monkeys.
Nagata T; Suzuki M; Fukazawa M; Honda K; Yamane M; Yoshida A; Azabu H; Kitamura H; Toyota N; Suzuki Y; Kawabe Y
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1520-33. PubMed ID: 24761001
[TBL] [Abstract][Full Text] [Related]
20. Combined 17beta-oestradiol and progesterone treatment prevents neuronal cell injury in cortical but not midbrain neurones or neuroblastoma cells.
Lorenz L; Dang J; Misiak M; Tameh Abolfazl A; Beyer C; Kipp M
J Neuroendocrinol; 2009 Oct; 21(10):841-9. PubMed ID: 19686448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
